MX2014000744A - Métodos de tratamiento del dolor. - Google Patents

Métodos de tratamiento del dolor.

Info

Publication number
MX2014000744A
MX2014000744A MX2014000744A MX2014000744A MX2014000744A MX 2014000744 A MX2014000744 A MX 2014000744A MX 2014000744 A MX2014000744 A MX 2014000744A MX 2014000744 A MX2014000744 A MX 2014000744A MX 2014000744 A MX2014000744 A MX 2014000744A
Authority
MX
Mexico
Prior art keywords
methods
treating pain
directed
subject matter
disclosed subject
Prior art date
Application number
MX2014000744A
Other languages
English (en)
Other versions
MX350463B (es
Inventor
Daniel B Carr
Peter Lacouture
De Rocha Marcelona Garcia
Original Assignee
Hospira Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospira Inc filed Critical Hospira Inc
Publication of MX2014000744A publication Critical patent/MX2014000744A/es
Publication of MX350463B publication Critical patent/MX350463B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La materia actualmente divulgada está dirigida a métodos para tratar dolor post-operatorio administrando una combinación de una dosis aprobada de inferior a mínima de diclofenaco y beta-ciclodextrina; la materia actualmente divulgada también está dirigida a métodos para tratar el dolor en mamíferos de alto riesgo u obesos que necesitan analgesia.
MX2014000744A 2011-07-20 2012-07-19 Métodos de tratamiento del dolor. MX350463B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161509886P 2011-07-20 2011-07-20
PCT/US2012/047453 WO2013013076A1 (en) 2011-07-20 2012-07-19 Methods of treating pain

Publications (2)

Publication Number Publication Date
MX2014000744A true MX2014000744A (es) 2014-05-14
MX350463B MX350463B (es) 2017-09-06

Family

ID=47558482

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014000744A MX350463B (es) 2011-07-20 2012-07-19 Métodos de tratamiento del dolor.

Country Status (16)

Country Link
US (1) US20140221490A1 (es)
EP (2) EP2734212B1 (es)
JP (2) JP6320917B2 (es)
KR (1) KR20140063583A (es)
CN (1) CN103781484A (es)
AU (1) AU2012283915B2 (es)
BR (1) BR112014001335A2 (es)
CA (1) CA2841964A1 (es)
DK (1) DK2734212T3 (es)
ES (1) ES2646226T3 (es)
IL (1) IL230433A0 (es)
IN (1) IN2014CN00315A (es)
MX (1) MX350463B (es)
MY (1) MY166036A (es)
NO (1) NO2854815T3 (es)
WO (1) WO2013013076A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2522343A1 (en) * 2006-03-28 2012-11-14 Javelin Pharmaceuticals, Inc. Formulations of Low Dose Diclofenac and Beta-Cyclodextrin
US7943591B2 (en) 2007-05-11 2011-05-17 Adynxx, Inc. Gene expression and pain
PL3456707T3 (pl) 2007-11-06 2020-09-21 Ptc Therapeutics, Inc. Pochodne 4-(p-chinonylo)-2-hydroksybutanamidu do leczenia chorób mitochondrialnych
ES2724851T3 (es) 2012-05-10 2019-09-16 Adynxx Inc Formulaciones para el suministro de principios activos
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
EP3180434B1 (en) 2014-08-15 2019-07-17 Adynxx, Inc. Oligonucleotide decoys for the treatment of pain
US20200017853A1 (en) * 2016-02-29 2020-01-16 Adynxx, Inc. Compositions and methods for pain amelioration via modification of gene expression
US20180025116A1 (en) * 2016-07-22 2018-01-25 Arizona Board Of Regents On Behalf Of University Of Arizona Clinical Event Management and Communication System
US20200027555A1 (en) * 2018-07-17 2020-01-23 Lewis Pharmaceutical Information, Inc. Patient centric drug analysis platform
US20230082544A1 (en) * 2020-02-18 2023-03-16 Novo Nordisk A/S Pharmaceutical formulations
CN111494446B (zh) * 2020-05-18 2021-08-17 深圳市宝安中医院（集团） 治疗胆绞痛的中药组合物及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
GB8506792D0 (en) 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US6407079B1 (en) 1985-07-03 2002-06-18 Janssen Pharmaceutica N.V. Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
US5002935A (en) 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5389681A (en) 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
IL111184A (en) 1993-10-08 2000-08-13 Farmarc Nederland B V Of Cito Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin
ZA949182B (en) 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
WO2001098329A1 (en) 2000-06-22 2001-12-27 Theravance, Inc. Polyhydroxy glycopeptide derivatives
EP1467770A1 (en) 2002-01-15 2004-10-20 ALTANA Pharma AG Pantoprazole cyclodextrin inclusion complexes
US6869939B2 (en) 2002-05-04 2005-03-22 Cydex, Inc. Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
AU2003286883A1 (en) * 2003-11-04 2004-06-06 Otis Elevator Company Automatic passenger conveyor slow speed operation
WO2005092387A1 (en) 2004-03-10 2005-10-06 Shimoda Biotech (Pty) Ltd Stable injectable diclofenac compositions
US20070232567A1 (en) * 2006-03-28 2007-10-04 Curtis Wright Formulations Of Low Dose Non-Steroidal Anti-Inflammatory Drugs And Beta-Cyclodextrin
EP2522343A1 (en) * 2006-03-28 2012-11-14 Javelin Pharmaceuticals, Inc. Formulations of Low Dose Diclofenac and Beta-Cyclodextrin
CN101264086A (zh) 2007-03-14 2008-09-17 南京师范大学 含有头孢克肟环糊精包合物的药物组合物及其制备方法
WO2009089269A1 (en) * 2008-01-07 2009-07-16 Javelin Pharmaceuticals, Inc. Methods of treating pain while minimizing adverse effects on platelet function
US7662858B2 (en) * 2008-05-23 2010-02-16 Aaipharma, Inc. Method of treating post-surgical acute pain

Also Published As

Publication number Publication date
KR20140063583A (ko) 2014-05-27
EP3257505A1 (en) 2017-12-20
ES2646226T3 (es) 2017-12-12
IN2014CN00315A (es) 2015-04-03
AU2012283915B2 (en) 2016-11-24
MX350463B (es) 2017-09-06
US20140221490A1 (en) 2014-08-07
WO2013013076A1 (en) 2013-01-24
CA2841964A1 (en) 2013-01-24
IL230433A0 (en) 2014-03-31
EP2734212A4 (en) 2014-12-24
CN103781484A (zh) 2014-05-07
JP2017110022A (ja) 2017-06-22
BR112014001335A2 (pt) 2017-02-21
DK2734212T3 (da) 2017-11-06
JP6320917B2 (ja) 2018-05-09
MY166036A (en) 2018-05-21
JP2014520893A (ja) 2014-08-25
EP2734212B1 (en) 2017-09-06
EP2734212A1 (en) 2014-05-28
NO2854815T3 (es) 2018-04-21
AU2012283915A1 (en) 2014-02-06

Similar Documents

Publication Publication Date Title
MX2014000744A (es) Métodos de tratamiento del dolor.
CY1124307T1 (el) Φαρμακευτικη συνθεση, μεθοδοι θεραπειας και χρησεις αυτων
TN2014000206A1 (en) Antibody molecules having specificity for human ox40
NZ610034A (en) Prevention of adverse effects caused by cd3 specific binding domains
NZ626954A (en) Combination therapy of antibodies against human csf-1r and uses thereof
MX2019001977A (es) Metodos y composiciones para tratar esclerosis multiple y trastornos relacionados.
IN2014KN00996A (es)
MX2013012253A (es) Conjugados novedosos de aglutinante-farmaco (adc) y su uso.
NZ705008A (en) Novel modulators and methods of use
BR112014031806A8 (pt) método para tratamento de câncer positivo para gd2
AU2012229123A8 (en) Methods of treating breast cancer with anthracycline therapy
MX356728B (es) Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2.
MX2012000949A (es) Terapias de combinacion con moduladores de ck2.
TN2012000610A1 (en) Heterocyclic compounds, their preparation and their therapeutic application
NZ628433A (en) Chitosan-derived compositions
MX2013007171A (es) Inductor de autofagia y terapia de combinacion inhibidora para el tratamiento de neoplasias.
MX364220B (es) Metodos de tratamientos de fibrosis.
IN2014DN08385A (es)
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
MX356317B (es) Tratamiento de síntomas asociados a gastroparesia femenina.
IN2014CN02315A (es)
WO2012044963A3 (en) Perfluorocarbons for use in treating pruritus
MX2011007384A (es) Terapias de combinacion para trastornos neoplásticos.
TN2014000418A1 (en) Methods for treating cancer using pi3k inhibitor and mek inhibitor
MX359171B (es) Tratamiento para diabetes tipo i y tipo ii.

Legal Events

Date Code Title Description
FG Grant or registration